Statistics for Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma
Total visits
| views | |
|---|---|
| Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial Carcinoma | 3 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:4cc74d7c-0bac-41ce-a9eb-7ea74ce5e62e | 19 |
| java.util.UUID:dfbb5216-fe04-4df6-bee0-7545fc2f60a6 | 18 |
| java.util.UUID:3df9f8e9-d2fc-40ac-b15c-1d01bb52d9d9 | 6 |
| Jun2022PhaseII-CCBYNC.pdf | 4 |
Top country views
| views | |
|---|---|
| United States | 3 |
Top city views
| views | |
|---|---|
| Greenwood | 2 |
| Indianapolis | 1 |